Long-Term Treatment Sequelae After External Beam Irradiation With or Without Hormonal Manipulation for Adenocarcinoma of the Prostate: Analysis of Radiation Therapy Oncology Group Studies 85-31, 86-10, and 92-02

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 2, 2008, Pages 437-441

  Lawton, Colleen A ^a   Bae, Kyoungwha ^b   Pilepich, Miljenko ^c   Hanks, Gerald ^c   Shipley, William ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c Massachusetts General Hospital ^*

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Hormone therapy; Prostate cancer; Toxicity

Indexed keywords

HORMONES; ONCOLOGY; PROBABILITY DISTRIBUTIONS; TOXICITY; TUMORS;

HORMONE THERAPY; PROSTATE CANCER;

RADIOTHERAPY;

FLUTAMIDE; GOSERELIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASCITES; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVOR; CYSTITIS; EXTERNAL BEAM RADIOTHERAPY; FISTULA; FOLLOW UP; HEMATURIA; HUMAN; INTERMETHOD COMPARISON; INTESTINE PERFORATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; PAIN; PATIENT SAFETY; PERITONITIS; PRIORITY JOURNAL; PROCTITIS; PROSTATE ADENOCARCINOMA; RADIATION INJURY; RECTOURETHRAL FISTULA; RECTOVESICLE FISTULA; RECTUM HEMORRHAGE; SEPSIS; SHORT COURSE THERAPY; SMALL INTESTINE OBSTRUCTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 38149087621     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.050     Document Type: Article

References (9)

1. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the RTOG and EORTC. Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
2. Lawton C.A., Won M., Pilepich M., et al. Long-term treatment sequelae after external beam radiation for adenocarcinoma of the prostate: Analysis of RTOG studies 75-06 and 77-06. Int J Radiat Oncol Biol Phys 21 (1991) 935-939
3. Pilepich M., Winter K., Lawton C., et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 61 (2005) 1285-1290
4. Pilepich M., Winter K., John M., et al. Phase III RTOG trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 50 (2001) 1243-1252
5. Hanks G., Pajak T., Porter A., et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: RTOG protocol 92-02. J Clin Oncol 21 (2003) 3972-3978
6. th Annual ASTRO Meeting 2006;66:3(Abstract 22, p S13).
7. Sanguineti G., Agostinelli S., Foppiano F., et al. Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma. Br J Cancer 86 (2002) 1843-1847
8. Liu M., Pickles T., Agranovich A., et al. Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Rad Oncol Biol Phys 58 (2004) 59-67
9. Cox D.R. Regression models and life tables. J R Stat Soc Series B 34 (1972) 187-229